Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
Genmab
Genmab
USWM, LLC (dba US WorldMeds)
USWM, LLC (dba US WorldMeds)
BriaCell Therapeutics Corporation
Acerta Pharma BV
Eli Lilly and Company
Center for International Blood and Marrow Transplant Research
Centre Oscar Lambret
Centre Oscar Lambret
St. Jude Children's Research Hospital
Centre Oscar Lambret
Emory University
USWM, LLC (dba US WorldMeds)
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
Essen Biotech
National Institutes of Health Clinical Center (CC)
Center for International Blood and Marrow Transplant Research
University of Wisconsin, Madison
Children's Hospital Los Angeles
Gustave Roussy, Cancer Campus, Grand Paris
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
University of Ulm
Jonsson Comprehensive Cancer Center
University of California, San Diego
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Actuate Therapeutics Inc.
University Health Network, Toronto
SynerGene Therapeutics, Inc.
Thomas Jefferson University
CARGO Therapeutics
Thomas Jefferson University
Peking University
Immatics US, Inc.
Genmab
Pfizer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bristol-Myers Squibb
Genmab
Vastra Gotaland Region
Karolinska University Hospital
Adaptimmune
Adaptimmune
Adaptimmune